Fortress Biotech, Inc. - 27 Jun 2024 Form 4 Insider Report for MUSTANG BIO, INC. (MBIO)

Role
10%+ Owner
Signature
/s/ Samuel Berry, General Counsel and Authorized Agent
Issuer symbol
MBIO
Transactions as of
27 Jun 2024
Net transactions value
$0
Form type
4
Filing time
28 Jun 2024, 16:22:34 UTC
Previous filing
24 May 2024
Next filing
01 Oct 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MBIO COMMON STOCK, PAR VALUE $0.0001 Award $0 +575,191 +30% $0.000000 2,502,991 27 Jun 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Fortress Biotech, Inc. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The Issuer is required to grant to the Reporting Person an equity fee in shares of the Issuer's Common Stock equal to 2.5% of the gross amount of any debt or equity financing consummated by the Issuer. 575,191 shares were granted by the Issuer to the Reporting Person following the closing of equity financings.